Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Wipro Lt 559.50 3.82
Tata Stl 458.95 0.40
Tata Pow 88.00 0.28
Ong Corp 403.25 0.80
Hindalco 149.65 0.81
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Glaxo SmithKline Pharmaceuticals Limited
Glaxo SmithKline Pharmaceuticals Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500660NSE:GLAXOBloomberg:GLXO@INReuters:GLAX.BO
Market Lot: 1Face Value: 10ISIN Demat: INE159A01016
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
12-AUG-14 Glaxo SmithKline Pharmaceuticals disclosed a sharp drop in standalone net profit for the quarter ended June 2014. During the quarter, the profit of the company declined 14.56% to Rs 982.90 million from Rs 1,150.40 million in the same quarter last year. 10-MAR-14 GlaxoSmithKline plc announced today that, following the voluntary open offer undertaken by its subsidiary, GlaxoSmithKline, GSK has successfully increased its stake in its pu...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Glaxo SmithKline Pharmaceuticals standalone quarterly net falls 14.56%   -IRIS 12-Aug-14
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2014(6)31-Dec-2013 (12)31-Dec-2012 (12)
Net sales 12548.1025201.7025999.30
Other Income847.202009.701934.80
Total Income13395.3027211.4027934.10
Cost of goods sold10478.4020240.7018111.60
OPBDIT2916.906970.709822.50
PAT1948.305018.805772.60
Gross Block---
Equity capital847.00847.00847.00
EPS (Rs.)-59.3068.20
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-33.81 - 50.6228.09 - 34.28
Debt / Equity (x)---
Operating margin (% of OI)21.825.635.2
Net margin (% of OI)14.518.420.7
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
GSK House
Dr. Annie Besant Road
Mumbai
Maharashtra-400 030
PHONE
(022) 2495 9595
FAX
(022) 2495 9494
 
Board of Directors
Board Meetings
Date Purpose
06-NOV-14 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer